Michael P. Dube, VP, Chief Accounting Officer: Intellia Therapeutics NTLA Sell · Filed 25/07/03

Trade details

Type: Insider sale
Amount: $24,904.85
Shares · price: 2,503 sh · $9.95 a share
Held after: 57,137 sh
Stock: Intellia Therapeutics NTLA
Person: Michael P. DubeVP, Chief Accounting Officer
Trade date: 25/07/02
Filed: 25/07/03
Days to filing: 1 days

Sold 4.2% of holdings

Share of holding sold: 4.2%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/02~25/08/01

Michael P. Dube's recent trades

Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$27.5K
2,989 sh
$27.5K
Filed 01/07
Traded 01/05
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$32.5K
1,871 sh
$32.5K
Filed 25/10/03
Traded 25/10/01
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$16.7K
1,372 sh
$16.7K
Filed 25/01/07
Traded 25/01/03
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$38.2K
2,012 sh
$38.2K
Filed 24/10/04
Traded 24/10/02

Michael P. Dube, CAO — sold $24.9K of Intellia Therapeutics NTLA · 4.2% of holdings | Whalegun